Furthermore, AHNAK knockdown restored the reduced migratory and invasive capacity of HCC cells due to RNF38 downregulation, which appears to indicate the presence of AHNAK as an oncogenic factor in hepatocellular carcinoma (80). Here, AHNAK is linked to hepatocellular carcinoma.